The NSW Government will continue its involvement in collaborative invasive species research and innovation under the new Centre for Invasive Species Solutions, while the Plant Biosecurity CRC is celebrating a win for its Pestpoint software at Collaborate | Innovate 2017.
Researchers are one step closer to a treatment that could 'turn off' the immune response that causes common allergies, including asthma — which affects over two million Australians.
Cost-competitiveness, high-quality data and fast study start-up times are some of the key factors that make Australia an attractive market for clinical trials. But as other countries strive to improve their clinical competitiveness, can Australia hold a dominant position?
US researchers have discovered a biochemical signalling process that causes densely packed cancer cells to break away from a tumour and spread the disease elsewhere in the body.
Scientists have created designer viruses that alert the immune system and cause it to send killer cells to help fight cancer.
Australian researchers have grown brain cells on a semiconductor wafer patterned with nanowires which act as a scaffold to guide the growth of brain cells.
UK researchers have uncovered the secret behind the explosive leaping ability of leafhopper insects — a discovery that could help create better technology in the future.
Cannabis has the potential to reverse brain ageing and improve memory function, a new European study has revealed.
US scientists have solved a major conundrum regarding the exact role of a protein in a critical cancer-linked pathway.
PreveCeutical Medical and UniQuest have partnered to develop a soluble gel to deliver cannabinoids directly to the brain via the nasal cavity.
US researchers have rewired mouse stem cells' genetic circuits to produce an anti-inflammatory arthritis drug when the cells encounter inflammation. The technique eventually could act as a vaccine for arthritis and other chronic conditions.
Researchers at Chalmers University of Technology have developed a method for finding new antibiotics from fungi.
Australian biotech and medical associations have come together to urge the government to "not devastate" the Australian MTP (medtech, biotech and pharmaceutical) sector "by gutting the Research & Development (R&D) Tax Incentive".